These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


120 related items for PubMed ID: 8330718

  • 1. [New aspects of effusion cytology in borderline ovarian cancer].
    Küpper T, Pfitzer P.
    Geburtshilfe Frauenheilkd; 1993 Jun; 53(6):420-4. PubMed ID: 8330718
    [Abstract] [Full Text] [Related]

  • 2. Giant condyloma acuminatum of the endocervix and lower uterine segment.
    Anderson VM, Savage EW, Chapman GW, Prater WF.
    J Reprod Med; 1979 Jul; 23(1):46-8. PubMed ID: 490492
    [Abstract] [Full Text] [Related]

  • 3. [Peritoneal cytology of uterine and ovarian cancer].
    Ikeda M, Noda K.
    Rinsho Byori; 1990 Nov; Suppl 87():176-89. PubMed ID: 2287087
    [No Abstract] [Full Text] [Related]

  • 4. Cytomorphology of adult granulosa cell tumor in ascitic fluid.
    Azad K, Khunger JM.
    Indian J Pathol Microbiol; 2010 Nov; 53(1):119-21. PubMed ID: 20090239
    [Abstract] [Full Text] [Related]

  • 5. Scoring system for differential diagnosis of malignant mesothelioma and reactive mesothelial cells on cytology specimens.
    Kimura N, Dota K, Araya Y, Ishidate T, Ishizaka M.
    Diagn Cytopathol; 2009 Dec; 37(12):885-90. PubMed ID: 19572412
    [Abstract] [Full Text] [Related]

  • 6. The diagnostic role of claudins in serous effusions.
    Kleinberg L, Holth A, Fridman E, Schwartz I, Shih IeM, Davidson B.
    Am J Clin Pathol; 2007 Jun; 127(6):928-37. PubMed ID: 17509990
    [Abstract] [Full Text] [Related]

  • 7. [Living cytology in the diagnosis of malignant ovarian tumor].
    Tanaka Y, Ueda G, Hiramatsu K, Inoue Y, Saito J, Nishino T, Sato Y, Yamasaki M, Inoue M, Kurachi K.
    Nihon Sanka Fujinka Gakkai Zasshi; 1983 Jul; 35(7):934-8. PubMed ID: 6875345
    [Abstract] [Full Text] [Related]

  • 8. Serous surface papillary carcinoma of the ovary: a clinical, pathologic, ultrastructural, and immunohistochemical study of 11 cases.
    White PF, Merino MJ, Barwick KW.
    Pathol Annu; 1985 Jul; 20 Pt 1():403-18. PubMed ID: 2581219
    [No Abstract] [Full Text] [Related]

  • 9. Malignant effusions: from diagnosis to biology.
    Davidson B.
    Diagn Cytopathol; 2004 Oct; 31(4):246-54. PubMed ID: 15452897
    [Abstract] [Full Text] [Related]

  • 10. From Krukenberg to today: the ever present problems posed by metastatic tumors in the ovary. Part II.
    Young RH.
    Adv Anat Pathol; 2007 May; 14(3):149-77. PubMed ID: 17452813
    [Abstract] [Full Text] [Related]

  • 11. [An application of cytology for ovarian tumors].
    Saito M.
    Rinsho Byori; 1992 Feb; 40(2):156-62. PubMed ID: 1583788
    [Abstract] [Full Text] [Related]

  • 12. Positive effusion cytology as the initial presentation of malignancy.
    Monte SA, Ehya H, Lang WR.
    Acta Cytol; 1987 Feb; 31(4):448-52. PubMed ID: 3604540
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. [Condylomata acuminata of the uterine cervix. Malignant potential].
    Briones H, Dabancens A, Rosmanich A, Montoya D.
    Rev Chil Obstet Ginecol; 1983 Feb; 48(2):49-64. PubMed ID: 6681193
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Primary ovarian angiosarcoma presenting as malignant cells in ascites: case report and review of the literature.
    Davidson B, Abeler VM.
    Diagn Cytopathol; 2005 May; 32(5):307-9. PubMed ID: 15830366
    [Abstract] [Full Text] [Related]

  • 17. Carbohydrate antigen expression in primary tumors, metastatic lesions, and serous effusions from patients diagnosed with epithelial ovarian carcinoma: evidence of up-regulated Tn and Sialyl Tn antigen expression in effusions.
    Davidson B, Berner A, Nesland JM, Risberg B, Kristensen GB, Tropé CG, Bryne M.
    Hum Pathol; 2000 Sep; 31(9):1081-7. PubMed ID: 11014575
    [Abstract] [Full Text] [Related]

  • 18. Squamous cell carcinoma of the cervix simulating an advanced malignancy of the ovaries.
    Obisesan KA, Adeyemo AA, Fawole AO, Adesina OA.
    Afr J Med Med Sci; 1998 Sep; 27(1-2):135-6. PubMed ID: 10456147
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Expression of the folate receptor genes FOLR1 and FOLR3 differentiates ovarian carcinoma from breast carcinoma and malignant mesothelioma in serous effusions.
    Yuan Y, Nymoen DA, Dong HP, Bjørang O, Shih IeM, Low PS, Trope' CG, Davidson B.
    Hum Pathol; 2009 Oct; 40(10):1453-60. PubMed ID: 19454358
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 6.